DR & DME: Addressing Barriers to Early Treatment

By: Rishi P. Singh, MD (Chair); Jordana G. Fein, MD, MS; Steven G. Ferrucci, OD, FAAO; Jaya Badhwar Kumar, MD; Joseph J. Pizzimenti, OD, FAAO

Begin Course

This course has expired. You can still review the content but course credit is no longer available.

Supplement Credits: 1

This continuing education (CE) activity captures content from a virtual roundtable discussion.

This supplement summarizes a roundtable discussion among retina specialists and optometrists on the topic of collaboration for improved care of patients with diabetes. The clinicians review the latest trial data and share their experiences related to the importance of imaging and how early treatment can preserve vision in patients with diabetes.

This certified CE activity is designed for optometrists.

Expiration Date: Thursday, June 1, 2023

Release Date: August 13, 2021

This activity is supported by unrestricted educational grant from Regeneron Pharmaceuticals.

Learning Objectives

Upon completion of this activity, the participant should be able to:

Discuss the benefits of telemedicine for continued screening of diabetic patients for diabetic retinopathy (DR) and diabetic macular edema (DME) in order to provide timely treatment.
Execute appropriate referrals of patients with DR and DME by working with your network to understand the need for timely referrals to a retina specialist based on the latest clinical data.
Interpret clinical data supporting the treatment of patients with moderate NPDR without macular edema with anti-VEGF therapy.
Discuss longer duration therapies for DME and NPDR that are currently under investigation.

Accreditation and Designation Statement

Participation Method

In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS

Hardware Requirements:
4GB+ RAM
Recommended internet speed 5Mbps+

Faculty and Disclosures

Rishi P. Singh, MD (Chair)

Program Chair
Cleveland Clinic
Cleveland, OH

Jordana G. Fein, MD, MS

Retina Group of Washington
Fairfax, VA

Steven G. Ferrucci, OD, FAAO

Chief of Optometry
Sepulveda VA Clinic
Los Angeles, CA

Jaya Badhwar Kumar, MD

Florida Retina Institute
Orlando, FL

Joseph J. Pizzimenti, OD, FAAO

Professor
University of the Incarnate Word
The Eye Care Institute
San Antonio, TX

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.

The following faculty/staff members have the following financial relationships with commercial interests:

Rishi P. Singh, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon Vision, Apellis, Bausch + Lomb, Genentech, Graybug, Gyroscope, Novartis, and Regeneron Pharmaceuticals. Grant/Research Support: Apellis.

Jordana G. Fein, MD, MS, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Bausch + Lomb and Regeneron Pharmaceuticals. Speaker’s Bureau and Stock/Shareholder: Regeneron Pharmaceuticals.

Steven G. Ferrucci, OD, FAAO, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Maculogix, Notal Vision, Optovue, Science Based Health, and Visible Genomics. Speaker’s Bureau: Genentech and Regeneron Pharmaceuticals.

Jaya Badhwar Kumar, MD, has no financial agreements or affiliation commercial interests.

Joseph J. Pizzimenti, OD, FAAO, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Carl Zeiss Meditec and EyePromise.

The Evolve staff and planners have no financial relationships with commercial interests. Michelle Dalton, writer, has no financial relationships with commercial interests.

Disclaimer

OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Modern Optometry, or Regeneron Pharmaceuticals.